Atlas Trials

Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer

Clinical trial NCT04225910 · UNKNOWN

Trial details

NCT number
NCT04225910
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2020-01-01
Primary completion
2021-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.